These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 649062)

  • 21. Influence on 5-[3H]hydroxytryptamine binding site development in chick embryo by serotonergic compounds.
    Soblosky JS; Jeng I
    J Neurochem; 1985 Feb; 44(2):544-51. PubMed ID: 2578180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of planarian serotonin receptor by ligand binding and PCR studies.
    Saitoh O; Yuruzume E; Nakata H
    Neuroreport; 1996 Dec; 8(1):173-8. PubMed ID: 9051775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of a 5-HT receptor in locust nervous tissue.
    Wedemeyer S; Roeder T; Gewecke M
    Eur J Pharmacol; 1992 Nov; 223(2-3):173-8. PubMed ID: 1362163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem.
    Palacios JM; Probst A; Cortes R
    Brain Res; 1983 Sep; 274(1):150-5. PubMed ID: 6616253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
    Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
    Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of serotonin receptors in post-mortem human brain.
    Whitaker PM
    J Histochem Cytochem; 1982 Aug; 30(8):828-31. PubMed ID: 7119425
    [No Abstract]   [Full Text] [Related]  

  • 27. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.
    Huang X; Marona-Lewicka D; Pfaff RC; Nichols DE
    Pharmacol Biochem Behav; 1994 Mar; 47(3):667-73. PubMed ID: 8208787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo receptor binding: attempts to improve specific/non-specific ratios.
    Niehoff DL; Palacios JM; Kuhar MJ
    Life Sci; 1979 Sep; 25(10):819-26. PubMed ID: 491833
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin receptors in the tissues of adult Ascaris suum.
    Chaudhuri J; Donahue MJ
    Mol Biochem Parasitol; 1989 Jul; 35(3):191-8. PubMed ID: 2747743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluids.
    Nelson CC; Foltz RL
    J Chromatogr; 1992 Sep; 580(1-2):97-109. PubMed ID: 1400834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.
    Monte AP; Marona-Lewicka D; Kanthasamy A; Sanders-Bush E; Nichols DE
    J Med Chem; 1995 Mar; 38(6):958-66. PubMed ID: 7699712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental changes in [3H]lysergic acid diethylamide ([3H]LSD) binding to serotonin receptors in the human brainstem.
    Zec N; Filiano JJ; Panigrahy A; White WF; Kinney HC
    J Neuropathol Exp Neurol; 1996 Jan; 55(1):114-26. PubMed ID: 8558166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain.
    Nakada MT; Wieczorek CM; Rainbow TC
    Neurosci Lett; 1984 Aug; 49(1-2):13-8. PubMed ID: 6493586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
    Egan CT; Herrick-Davis K; Miller K; Glennon RA; Teitler M
    Psychopharmacology (Berl); 1998 Apr; 136(4):409-14. PubMed ID: 9600588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A detailed protocol for the in vitro radioautographic visualization of serotonergic receptors.
    Meibach RC
    J Histochem Cytochem; 1982 Aug; 30(8):831-6. PubMed ID: 7119426
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
    Boess FG; Monsma FJ; Sleight AJ
    J Neurochem; 1998 Nov; 71(5):2169-77. PubMed ID: 9798944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding site.
    Boess FG; Monsma FJ; Bourson A; Zwingelstein C; Sleight AJ
    Ann N Y Acad Sci; 1998 Dec; 861():242-3. PubMed ID: 9928266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.